ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "HER2-Positive Metastatic Breast Cancer: What’s New in Treatment and Quality-of-Life"
Episode Synopsis
- HER2-Positive Metastatic Breast Cancer
- Biomarker, Genomic & Diagnostic Testing: Grade & Hormone Receptors
- Standard Treatment Options, Including Targeted Therapy
- How Biomarker Testing Informs Treatment Decisions
- New & Emerging Targeted Treatments
- Updates on Investigational New Drugs in Clinical Trials
- How Research Contributes to Your Treatment Options
- What’s New in the Prevention & Management of Treatment Side Effects, Symptoms, Discomfort, Neuropathy, Pain & Long-Term Effects
- Guidelines to Prepare for Telemedicine/Telehealth Appointments, Including Technology, Prepared List of Questions & Discussion of OpenNotes
- Key Questions to Ask Your Health Care Team About Quality-of-Life Concerns
- Questions for Our Panel of Experts
- Biomarker, Genomic & Diagnostic Testing: Grade & Hormone Receptors
- Standard Treatment Options, Including Targeted Therapy
- How Biomarker Testing Informs Treatment Decisions
- New & Emerging Targeted Treatments
- Updates on Investigational New Drugs in Clinical Trials
- How Research Contributes to Your Treatment Options
- What’s New in the Prevention & Management of Treatment Side Effects, Symptoms, Discomfort, Neuropathy, Pain & Long-Term Effects
- Guidelines to Prepare for Telemedicine/Telehealth Appointments, Including Technology, Prepared List of Questions & Discussion of OpenNotes
- Key Questions to Ask Your Health Care Team About Quality-of-Life Concerns
- Questions for Our Panel of Experts
More episodes of the podcast All CancerCare Connect Education Workshops
Living with Small Cell Lung Cancer
16/09/2025
Bladder Cancer: Treatment Updates
20/08/2025
Update on Epithelioid Sarcoma
18/07/2025
Liver Cancer: Treatment Update
30/06/2025
In God we trust